The US FDA issued a memo on vaccine coadministration and approval requirements. ACIP meeting set for Sept. 18-19. Pfizer/BioNTech’s Comirnaty accounts for 8% of Pfizer’s revenue and most of BioNTech’s profits. HHS Secretary Kennedy Jr. is creating barriers to vaccine administration. Forecasts for Pfizer and BioNTech lowered due to concerns about vaccine access and uptake.

Read more at Morningstar: Slightly Lowering Our MRNA Vaccine Forecast Due to US Policy Headwinds